🔴 Johnson & Johnson is trading 5.6% down after MedTech sales missed estimates

Johnson & Johnson is trading at €222.15 (-5.61%) after its October 13 MedTech sales missed analysts’ estimate.

• MedTech sales grew 2.5% to $8.6 billion, below the $8.71 billion estimate; Reuters reported shares fell more than 6% that day.
• The company beat adjusted EPS expectations and raised its 2026 guidance, but weaker medical-device results overshadowed those positives. No separate October 14 company announcement is identified in available reporting.